Опубликовано в "Бизнес, Бизнес", язык - English. 3 страниц.
The global biosimilars market is expected to reach USD 13.1 billion by 2024 on account of increase in the prevalence of chronic diseases such as cancer, diabetics, cardiac disorders and autoimmune diseases. Еще
